Clinical Trials on Disseminated Sclerosis
Total 4577 results
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Novartis PharmaceuticalsCompletedMultiple SclerosisRussian Federation, Ukraine, Czech Republic
-
Isfahan University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenGB Pharma Services & Consulting s.r.l.Withdrawn
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Bristol-Myers SquibbTerminated
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Cantonal Hospital of St. GallenCompletedMultiple Sclerosis, Relapsing Remitting
-
Bayhill TherapeuticsCompletedRelapsing Remitting Multiple Sclerosis
-
Jubilee Mission Medical College and Research InstituteCompletedCoagulopathy, Consumption | SnakebiteIndia
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
Washington University School of MedicineMassachusetts General HospitalSuspendedAmyotrophic Lateral Sclerosis, Familial | Amyotrophic Lateral Sclerosis, SporadicUnited States
-
University College, LondonLondon School of Hygiene and Tropical Medicine; The Leeds Teaching Hospitals... and other collaboratorsActive, not recruitingSecondary Progressive Multiple Sclerosis (SPMS)United Kingdom
-
Queen Mary University of LondonBarts & The London NHS Trust; National Institute for Health Research, United... and other collaboratorsRecruitingProgressive Multiple Sclerosis | Advanced Multiple SclerosisUnited Kingdom
-
University of LincolnNottingham University Hospitals NHS TrustCompletedDepression | Secondary-progressive Multiple SclerosisUnited Kingdom
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
Rigshospitalet, DenmarkDanish Research Centre for Magnetic ResonanceUnknownMultiple Sclerosis (Primary or Secondary Progressive Phase).Denmark
-
BiogenRecruiting
-
Johns Hopkins UniversityCompletedProgressive Multiple SclerosisUnited States
-
SanofiCompletedProgressive Multiple SclerosisGermany
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
Indiana UniversityUniversity of Alabama at Birmingham; University of OttawaCompletedProgressive Multiple SclerosisUnited States
-
Nantes University HospitalCompletedProgressive Multiple SclerosisFrance
-
University of CalgaryCompletedMultiple Sclerosis, Primary ProgressiveCanada
-
National Institute of Allergy and Infectious Diseases...CompletedMultiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
Mansoura University HospitalUnknownMultiple Sclerosis | Sexual DysfunctionEgypt
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
North Bristol NHS TrustUniversity of Nottingham; Medical Research Council; University of Bristol; Bristol... and other collaboratorsUnknownProgressive Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisIreland
-
Universitätsklinikum Hamburg-EppendorfDeutsche Multiple Sklerose Gesellschaft HamburgUnknown
-
MedDay Pharmaceuticals SAUnknown
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedProgressive Multiple SclerosisUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisGermany